Endologix (ELGX) Misses Q4 EPS by 1c, FY EPS Guidance Falls Short
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts ELGX Hot Sheet
Price: $0.22 --0%
Financial Fact:
Loss from operations: -11.23M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
Loss from operations: -11.23M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Endologix (NASDAQ: ELGX) reported Q4 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $38.8 million versus the consensus estimate of $38.1 million.
Endologix sees FY2015 EPS of ($0.51)-($0.56), versus the consensus of ($0.42). Endologix sees FY2015 revenue of $159-165 million, versus the consensus of $163.4 million.
For earnings history and earnings-related data on Endologix (ELGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Top restaurant stocks to watch, according to Raymond James
- Coforge Ltd (COFORGE:IN) PT Raised to INR2,460 at UBS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
